Back

Exploring protein biomarkers of physical activity and cardiovascular disease

30 August 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: Role of exercise in primary and secondary prevention Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Malin Enarsson

Karolinska Institute, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Left ventricular volume as a predictor of exercise capacity and functional independence in individuals with preserved ejection fraction
Doctor M. Falter (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Incremental prognostic value of combined information of arterial stiffness and the result of treadmill exercise test in patients with suspected coronary artery disease
Doctor J. Chung (Goyang, KR)
Abstract Slides Video
Presentation thumbnail
Longitudinal associations between accelerometry-assessed sleep clusters and obesity in adolescence and young adulthood: the German GINIplus and LISA birth cohorts study
Ms M. Wang (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Impaired myocardial energetics and lower cardiac reserve in response to exercise stress in adults born preterm
Associate Professor A. Lewandowski (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Effectivess of non-pharmacological interventions on physical activity and sedentary behaviour among patients with coronary heart disease: a systematic review and meta-analysis
Ms E. Miu (Hong Kong Sar, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Role of exercise in primary and secondary prevention

The Event

Event poster

ESC Congress 2024

30 August 2024 08:00 CET
You may be interested in
thumbnail
Congress Session
Physical activity: enough or too much?
thumbnail
Congress Presentation
Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multi-system disease risks
thumbnail
Congress Presentation
Early post-discharge physical activity after myocardial infarction: safe and not linked to adverse outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources